Transepidermal water loss (TEWL) is a noninvasive biomarker for epidermal barrier integrity. TEWL has been a useful measurement in clinical trials for potential new therapies. 1,2 However, its incorporation into objective assessments in the clinic setting has been limited by the size and cost of most currently available devices, including the AquaFlux AF200 ® ("AquaFlux") unit (Biox Systems, LTD), which is most often used by researchers to measure TEWL. A pocket-sized, lightweight device has recently become available, the gpskin Barrier Light ® ("gpskin") (gpower, Inc), which transmits data using Bluetooth, costs much less than traditional devices, and does not require an equilibration period before use. The ichthyoses are a group of genetic disorders characterized by scaling, skin thickening, and cutaneous inflammation, which are thought to represent responses to the epidermal barrier abnormality. 3